Abstract: Described herein are a method for transferring an embossed structure, which includes at least the steps (1-i) and (2-i) or (1-ii) and (2-ii), where steps (1-i) and (2-i) or (1-ii) and (2-ii) are carried out using an embossing tool (P1) including at least one embossing die (p1), where the embossing die (p1) of the embossing tool (P1) is pretreated, before the implementation of step (2-i) or before the implementation of step (1-ii), with at least one organic solvent and/or at least one reactive diluent, and also a method of using a corresponding pretreated embossing tool (P1) including at least one embossing die (p1) for the purpose of transferring an embossed structure in such a way.

Abstract: Systems and methods determine an angle of an articulated trailer relative to a tractor that the trailer is hitched to. An optical encoder is positioned beneath a fifth-wheel of a tractor to couples with a kingpin of the trailer when the trailer is hitched to the tractor. The optical coupler has a rotating shaft that may include pins that physically interact with the kingpin and/or may include a magnet that magnetically attaches to the kingpin. A clearance and cleaning block may be positioned on the spring plate to interact with a bottom surface of a kingpin of the trailer during hitching of the trailer to the tractor. A LIDAR attached to the tractor may detect a front end of the trailer to determine the trailer angle relative to the tractor.

Abstract: A method, system, and computing capabilities are presented for improving visibility to resident payment trends, resident credit score trends, and anticipated rent income trends. A rent payment risk level of individual residents is evaluated based upon credit scores and historic rent payment information of residents. Resident risk evaluations are aggregated, producing a property stability score. Resident rent payment information may be provided to credit bureaus for incorporating into individual credit scores. High risk residents may be advised of financing options that are suitable for their needs.

Abstract: The present invention relates to methods and compositions useful for the detection and quantitation of analytes. The present invention has particular applicability to the detection and quantitation of analytes in samples of biological origin or that interact with biological systems.

Abstract: Described is a method for preventing and/or reducing the formation of neointima comprising delivering to cells of an individual angiotensin-(1-7) or a functional part, derivative and/or analogue thereof, wherein use is made of a delivery vehicle that includes means for releasing angiotensin-(1-7) or a functional part, derivative and/or analogue thereof. Also described is a delivery vehicle for preventing and/or reducing the formation of neointima, wherein the delivery vehicle comprises an implantable device which device includes means for releasing angiotensin-(1-7)or a functional part, derivative and/or analogue thereof.

Abstract: The invention provides a use of angiotensin-(1-7), or a functional part, derivative and/or analogue thereof, for the preparation of a medicament for enhancing cardiac function. For instance, left ventricular diastolic pressure, coronary flow, endothelial function and/or myocyte hypertrophy can he enhanced by a medicament of the invention. By enhancing cardiac function, the development of heart failure can he attenuated or prevented. The invention further comprises a pharmaceutical composition comprising angiotensin-(1-7), or a functional part, derivative and/or analogue thereof, and a carrier. A method for treating an animal suffering from, or at risk of suffering from, heart failure comprising administering to the animal a pharmaceutical composition of the present invention is also provided herein.

Abstract: The present invention provides compositions and methods for treating circulatory disorders, for treating myocardial infarctions, for producing cardiac muscle cells, and for treating injured tissue in an individual. More particularly, the present invention provides methods of treating circulatory disorders by administering an effective amount of a composition comprising an umbilical cord blood cell. In one embodiment, the circulatory disorder is myocardial infarction.